Early discharge with virtual follow-up for low-risk STEMI patients
Virtual Ward-Assisted Very earLy dIschArge of Low-rIsk STEMI patieNTs: the VALIANT-STEMI Trial
NA · The Leeds Teaching Hospitals NHS Trust · NCT06731257
This study is testing if low-risk heart attack patients can safely go home within 24 hours and have follow-up care by phone instead of staying in the hospital longer.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 600 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | The Leeds Teaching Hospitals NHS Trust (other) |
| Locations | 1 site (Leeds) |
| Trial ID | NCT06731257 on ClinicalTrials.gov |
What this trial studies
This trial investigates the safety and feasibility of early discharge (within 24 hours) for low-risk patients who have undergone successful treatment for ST elevation myocardial infarction (STEMI). Participants will be randomized to receive either standard care or early discharge with virtual follow-up via telephone. The primary outcome will be hospital readmission or all-cause mortality within 30 days post-discharge. The goal is to determine if this approach can reduce hospital stay while maintaining patient safety and well-being.
Who should consider this trial
Good fit: Ideal candidates are low-risk STEMI patients who have successfully undergone revascularization and meet specific inclusion criteria.
Not a fit: Patients with significant comorbidities or those unable to manage home monitoring will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to shorter hospital stays and improved patient satisfaction without compromising safety.
How similar studies have performed: While observational studies suggest early discharge is safe for low-risk patients, this randomized controlled trial approach is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Successful revascularisation following STEMI * Zwolle score \<=3 * No bystander disease awaiting inpatient intervention at the time of screening or consent (so if they have had intervention to a bystander vessel before this they would be eligible) Exclusion Criteria: * Haemodynamic instability (Killip class \>I) * Left ventricular ejection fraction \<45%\<40% * Sustained ventricular or atrial arrhythmias requiring intervention * No support at home or social or physical circumstances preventing early discharge * Unable to use home monitoring equipment * Unwilling to consent or follow instructions * Patients visiting from out of our catchment area * Out-of hospital cardiac arrest * Patients repatriated to their local hospital within 24 hours * New or worsening renal failure (i.e. creatinine \>=1.5x baseline)
Where this trial is running
Leeds
- Leeds Teaching Hospital NHS Trust — Leeds, United Kingdom (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cardiovascular